臨床試験の方法論

Clinical trial end points relevant to patients and society for rare cancers

Shelize Khakoo, Alexandros Georgiou & Ian Chau

• 抽象的な

医薬品の評価

Ferric citrate in end-stage kidney disease as a phosphate binder and source of iron: a review of clinical trials

Diana I Jalal, Mohammed Sika, Jamie P Dwyer, Ingrid J Chang, Barbara A Greco, Marvin Sinsakul, Simin Goral & Kausik Umanath

• 抽象的な

臨床試験の展望

Is social media suitable for patient recruitment?

Wolfgang Eglmeier

• 抽象的な

医薬品の評価

Velaglucerase alfa in the treatment of Gaucher disease type 1: an update

K Nicole Weaver, Gregory A Grabowski & Thomas A Burrow

• 抽象的な

臨床試験の展望

Monitoring randomized clinical trials in Africa; pragmatic approaches and experiences from HIV trials

Margaret J Thomason, Moira J Spyer1, Nicola Joffe1, Justine Boles, Andy Burke, Helen C Wilkes & Mary Rauchenberger

• 抽象的な

医薬品の評価

Updating the clinical evidence on belimumab role modulating B-cell response and treatment of systemic lupus erythematosus

Ignasi Rodriguez-Pinto, Gerard Espinosa1 & Ricard Cervera

• 抽象的な